title: Nandrolone treatment decreases the alpha1B-adrenoceptor mRNA level in rat kidney, but not the density of alpha1B-adrenoceptors in cultured MDCK-D1 kidney cells.
abstract: We have previously shown that treatment of rats with the anabolic androgen steroid nandrolone decreased the density of alpha1B-adrenoceptors in the rat kidney [Uhlén, S., Lindblom, J., Kindlundh, A., Muhisha, P., Nyberg, F., (2003). Nandrolone treatment decreases the level of rat kidney alpha1B-adrenoceptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 368, 91-98]. This effect may have been caused either by decreased de novo synthesis of alpha1B-adrenoceptors or by increased degradation of alpha1B-adrenoceptors [corrected] In the present study, we show that treatment of rats with nandrolone decreases the level of mRNA for the alpha1B-adrenoceptor in the kidneys, implying decreased synthesis of alpha1B-adrenoceptors. On the other hand, nandrolone did not decrease the density of alpha1B-adrenoceptors in Madin-Darby Canine Kidney (MDCK) cells, even though the sub-cell line tested, MDCK-D1, expresses both the androgen receptor and the alpha1B-adrenoceptor. It is concluded that the regulation of alpha1B-adrenoceptor expression by anabolic androgenic steroids is intricate and cell-type specific.
authors.affiliation: Department of Neuroscience, Division of Pharmacology, Uppsala University, Uppsala, Sweden.
authors.forename: Jonas
authors.initials: J
authors.lastname: Lindblom
authors.forename: Ramona
authors.initials: R
authors.lastname: Petrovska
authors.forename: Mathias
authors.initials: M
authors.lastname: Hallberg
authors.forename: Kristina
authors.initials: K
authors.lastname: Magnusson
authors.forename: Fred
authors.initials: F
authors.lastname: Nyberg
authors.forename: Staffan
authors.initials: S
authors.lastname: Uhlén
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D002460:Cell Line; D004285:Dogs; D015536:Down-Regulation / Q000187:drug effects / Q000235:genetics; D015870:Gene Expression / Q000187:drug effects; D007668:Kidney / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D008719:Methiothepin / Q000494:pharmacology; D009277:Nandrolone / Q000494:pharmacology*; D010879:Piperazines / Q000494:pharmacology; D016133:Polymerase Chain Reaction / Q000379:methods; D011224:Prazosin / Q000494:pharmacology; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D018340:Receptors, Adrenergic, alpha-1 / Q000235:genetics* / Q000378:metabolism; D011944:Receptors, Androgen / Q000235:genetics / Q000378:metabolism; D013045:Species Specificity; D014316:Tritium
chemical_list: C547718:Adra1b protein, rat; D000317:Adrenergic alpha-Antagonists; D010879:Piperazines; D012333:RNA, Messenger; D018340:Receptors, Adrenergic, alpha-1; D011944:Receptors, Androgen; D014316:Tritium; C057446:5-methylurapidil; D008719:Methiothepin; D009277:Nandrolone; C053428:BMY 7378; D011224:Prazosin